Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2007 5
2008 2
2009 3
2010 1
2011 4
2012 4
2013 6
2014 4
2015 5
2016 5
2017 3
2018 7
2019 3
2020 4
2021 5
2022 2
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based threshold.
Schmäche T, Fohgrub J, Klimova A, Laaber K, Drukewitz S, Merboth F, Hennig A, Seidlitz T, Herbst F, Baenke F, Ada AM, Groß T, Wenzel C, Ball CR, Praetorius C, Schmidt T, Ringelband-Schilling B, Koschny R, Stenzinger A, Roeder I, Jaeger D, Zeissig S, Welsch T, Aust D, Glimm H, Folprecht G, Weitz J, Haag GM, Stange DE. Schmäche T, et al. Among authors: jaeger d. Mol Cancer. 2024 Jan 10;23(1):10. doi: 10.1186/s12943-023-01919-3. Mol Cancer. 2024. PMID: 38200602 Free PMC article.
The Role and Therapeutic Targeting of CCR5 in Breast Cancer.
Hamid R, Alaziz M, Mahal AS, Ashton AW, Halama N, Jaeger D, Jiao X, Pestell RG. Hamid R, et al. Among authors: jaeger d. Cells. 2023 Sep 8;12(18):2237. doi: 10.3390/cells12182237. Cells. 2023. PMID: 37759462 Free PMC article. Review.
Impact of 68Ga-FAPI PET/CT on Staging and Oncologic Management in a Cohort of 226 Patients with Various Cancers.
Koerber SA, Röhrich M, Walkenbach L, Liermann J, Choyke PL, Fink C, Schroeter C, Spektor AM, Herfarth K, Walle T, Calais J, Kauczor HU, Jaeger D, Debus J, Haberkorn U, Giesel FL. Koerber SA, et al. Among authors: jaeger d. J Nucl Med. 2023 Nov;64(11):1712-1720. doi: 10.2967/jnumed.123.266046. Epub 2023 Sep 7. J Nucl Med. 2023. PMID: 37678928 Free PMC article.
Outcome and prognostic factors in patients undergoing salvage therapy for recurrent esophagogastric cancer after multimodal treatment.
Apostolidis L, Lang K, Sisic L, Busch E, Ahadova A, Wullenkord R, Nienhüser H, Billeter A, Müller-Stich B, Kloor M, Jaeger D, Haag GM. Apostolidis L, et al. Among authors: jaeger d. J Cancer Res Clin Oncol. 2023 Apr;149(4):1373-1382. doi: 10.1007/s00432-022-04016-y. Epub 2022 Apr 19. J Cancer Res Clin Oncol. 2023. PMID: 35441345 Free PMC article.
Pembrolizumab and maraviroc in refractory mismatch repair proficient/microsatellite-stable metastatic colorectal cancer - The PICCASSO phase I trial.
Haag GM, Springfeld C, Grün B, Apostolidis L, Zschäbitz S, Dietrich M, Berger AK, Weber TF, Zoernig I, Schaaf M, Waberer L, Müller DW, Al-Batran SE, Halama N, Jaeger D. Haag GM, et al. Among authors: jaeger d. Eur J Cancer. 2022 May;167:112-122. doi: 10.1016/j.ejca.2022.03.017. Epub 2022 Apr 12. Eur J Cancer. 2022. PMID: 35427833 Clinical Trial.
Publisher Correction: JunB is a key regulator of multiple myeloma bone marrow angiogenesis.
Fan F, Malvestiti S, Vallet S, Lind J, Garcia-Manteiga JM, Morelli E, Jiang Q, Seckinger A, Hose D, Goldschmidt H, Stadlbauer A, Sun C, Mei H, Pecherstorfer M, Bakiri L, Wagner EF, Tonon G, Sattler M, Hu Y, Tassone P, Jaeger D, Podar K. Fan F, et al. Among authors: jaeger d. Leukemia. 2021 Dec;35(12):3628. doi: 10.1038/s41375-021-01367-2. Leukemia. 2021. PMID: 34489554 Free PMC article. No abstract available.
JunB is a key regulator of multiple myeloma bone marrow angiogenesis.
Fan F, Malvestiti S, Vallet S, Lind J, Garcia-Manteiga JM, Morelli E, Jiang Q, Seckinger A, Hose D, Goldschmidt H, Stadlbauer A, Sun C, Mei H, Pecherstorfer M, Bakiri L, Wagner EF, Tonon G, Sattler M, Hu Y, Tassone P, Jaeger D, Podar K. Fan F, et al. Among authors: jaeger d. Leukemia. 2021 Dec;35(12):3509-3525. doi: 10.1038/s41375-021-01271-9. Epub 2021 May 18. Leukemia. 2021. PMID: 34007044 Free PMC article.
Predicting the Risk of Metastases by PSMA-PET/CT-Evaluation of 335 Men with Treatment-Naïve Prostate Carcinoma.
Koerber SA, Boesch J, Kratochwil C, Schlampp I, Ristau J, Winter E, Zschaebitz S, Hofer L, Herfarth K, Kopka K, Holland-Letz T, Jaeger D, Hohenfellner M, Haberkorn U, Debus J, Giesel FL. Koerber SA, et al. Among authors: jaeger d. Cancers (Basel). 2021 Mar 25;13(7):1508. doi: 10.3390/cancers13071508. Cancers (Basel). 2021. PMID: 33805971 Free PMC article.
Neoadjuvant anti-programmed death-1 immunotherapy by pembrolizumab in resectable non-small cell lung cancer: First clinical experience.
Eichhorn F, Klotz LV, Kriegsmann M, Bischoff H, Schneider MA, Muley T, Kriegsmann K, Haberkorn U, Heussel CP, Savai R, Zoernig I, Jaeger D, Thomas M, Hoffmann H, Winter H, Eichhorn ME. Eichhorn F, et al. Among authors: jaeger d. Lung Cancer. 2021 Mar;153:150-157. doi: 10.1016/j.lungcan.2021.01.018. Epub 2021 Jan 21. Lung Cancer. 2021. PMID: 33529989 Clinical Trial.
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.
André T, Shiu KK, Kim TW, Jensen BV, Jensen LH, Punt C, Smith D, Garcia-Carbonero R, Benavides M, Gibbs P, de la Fouchardiere C, Rivera F, Elez E, Bendell J, Le DT, Yoshino T, Van Cutsem E, Yang P, Farooqui MZH, Marinello P, Diaz LA Jr; KEYNOTE-177 Investigators. André T, et al. N Engl J Med. 2020 Dec 3;383(23):2207-2218. doi: 10.1056/NEJMoa2017699. N Engl J Med. 2020. PMID: 33264544 Free article. Clinical Trial.
61 results